Literature DB >> 8603337

Cytogenetic survey of 53 Moroccan patients with acute myeloblastic leukemia.

N Hda1, B Chadli, A Bousfiha, A Trachli, M Harif, A Benslimane.   

Abstract

We present a cytogenetic survey of chromosome aberrations for 53 Moroccan patients with acute myeloblastic leukemia (AML). Our 53 patients were 2 to 70 years old with 31 men and 22 women. The cytogenetic study was performed with the following three methods: first, relative proportion of normal (N) or abnormal (A) metaphases; second, presence of specific or random abnormalities; and third, karyotype complexity. Among 36 patients (67%) with a chromosomal abnormality, 18 (34%) showed a specific aberration. We have found t(9;22) in three patients (5%), chromosome 5 or 7 abnormality in six (11%), del(11)(q23) in three (6%), +21 in four (8%), and +8 in two (4%). Specific translocations associated with FAB type were found: t(8;21) with AML2 in 12 patients (23%) and t(9;11) with AML5 in one (2%). Rare abnormalities were also found: one patient with t(7;21) associated with AML2 and another patient with r(1) ring associated with AML1. We concluded that our study in a Moroccan population confirmed the relation between some specific abnormalities and the FAB classification. We have found a higher incidence for t(8;21) than usually described. Finally, we have identified chromosomal abnormalities t(7;21)(q22;p11) and r(1), rarely described before.

Entities:  

Mesh:

Year:  1996        PMID: 8603337     DOI: 10.1016/0165-4608(95)00188-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.

Authors:  C Cameron Yin; Lynne V Abruzzo; Xiaoyan Qiu; Effrosyni Apostolidou; Jorge E Cortes; L Jeffrey Medeiros; Gary Lu
Journal:  Cancer Genet Cytogenet       Date:  2009-07

2.  Complex Karyotype in Hematological Diseases: A 6-Year Single Centre Study from Pakistan.

Authors:  Samra Waheed; Jawad Hassan; Maliha Naz; Sidra Maqsood; Madiha Abid; Saira Shan; Muhammad Nadeem; Tahir S Shamsi
Journal:  J Oncol       Date:  2018-06-03       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.